OLA Blog

ASN 2016: Onco-Nephrology

Written by Meguid El Nahas on Wednesday, 23 November 2016. Posted in OLA Blog

ASN 2016: Onco-Nephrology
Prof Richard Glassock wrote: I went to a session on Onco-Nephrology at the ASN meeting yesterday.  Two randomized controlled trials of high-cut off (HCO) membrane intermittent hemodialysis compared to standard membrane hemodialysis for...

ASN 2016: Late Breaking Clinical Trials

Written by Meguid El Nahas on Sunday, 20 November 2016. Posted in OLA Blog

ASN 2016: Late Breaking Clinical Trials
Prof Arif Khwaja Reporting from Chicago: Late Breaking Clinical Trials LEADER study looking at Liraglutatide on renal outcomes in patients with T2DM. This was a huge study with over 8000 patients with T2DM at higher CV risk who were randomised...

PPIs & CKD: "Do No Harm"...?!

Written by Meguid El Nahas on Monday, 17 October 2016. Posted in OLA Blog

PPIs & CKD: "Do No Harm"...?!
BLOG BY PROFESSOR PIERRE DELANAYE: PPI and CKD: an association… but is it causality? Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease. JAMA Intern Med. 2016 Feb;176(2):238-46. doi: 10.1001/jamainternmed.2015.7193....

A RCT trial in hemodialysis patients: fistula

Written by Pierre Delanaye on Monday, 10 October 2016. Posted in OLA Blog

A RCT trial in hemodialysis patients: fistula
Lancet. 2016 Sep 10;388(10049):1067-74. doi: 10.1016/S0140-6736(16)30948-5. Epub 2016 Aug 1. Effect of regional versus local anaesthesia on outcome after arteriovenous fistula creation: a randomised controlled trial. Aitken...

Radiocontrast Nephrotoxicity: A Myth?!

Written by Meguid El Nahas on Friday, 07 October 2016. Posted in OLA Blog

Radiocontrast Nephrotoxicity: A Myth?!
J Am Soc Nephrol. 2016 Sep 29. pii: ASN.2016010021. [Epub ahead of print] Estimating the Risk of Radiocontrast-Associated Nephropathy. Wilhelm-Leen E, Montez-Rath ME, Chertow G Abstract Estimates of the incidence...

Highlights from the 17th IPNA Congress "Molecular stratification of the nephrotic syndrome”

Written by Neveen A Soliman on Wednesday, 05 October 2016. Posted in OLA Blog

Highlights from the 17th IPNA Congress "Molecular stratification of the nephrotic syndrome”
During the plenary session of the first day of the 17th International Pediatric Nephrology A ssociation Congress, September 20-24 in Iguacu, Brazil  Professor Moin A Saleem delivered the keynote talk entitled “Molecular...

Potassium and Mortality on Hemodialysis

Written by Meguid El Nahas on Monday, 26 September 2016. Posted in OLA Blog

Potassium and Mortality on Hemodialysis
Am J Nephrol. 2016;44(3):179-86. doi: 10.1159/000448341. Epub 2016 Sep 3. Serum Potassium Levels and Mortality in Hemodialysis Patients: A Retrospective Cohort Study Yusuf AA1, Hu...

Intensive BP Control: More of the same?!

Written by Meguid El Nahas on Tuesday, 06 September 2016. Posted in OLA Blog

Intensive BP Control: More of the same?!
BLOG BY PROF PIERRE DELANAYE Am J Nephrol. 2016;43(4):271-80. doi: 10.1159/000446122. Epub 2016 Apr 29. Cardiovascular Outcomes in Action to Control Cardiovascular Risk in Diabetes: Impact of Blood Pressure Level and Presence of Kidney...

Canaglifozin in Diabetic Nephropathy: Major Breakthrough or just good Anti-hypertensive?

Written by Meguid El Nahas on Friday, 02 September 2016. Posted in OLA Blog

Canaglifozin in Diabetic Nephropathy: Major Breakthrough or just good Anti-hypertensive?
J Am Soc Nephrol. 2016 Aug 18. pii: ASN.2016030278. [Epub ahead of print] Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects. Heerspink HJ1, Desai M2, Jardine M3, Balis...

Heat Stress Nephropathy (HSN): Whats in a Name...?!

Written by Meguid El Nahas on Thursday, 01 September 2016. Posted in OLA Blog

Heat Stress Nephropathy (HSN): Whats in a Name...?!
Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1472-83. doi: 10.2215/CJN.13841215. Epub 2016 May 5. Climate Change and the Emergent Epidemic of CKD from Heat Stress in Rural Communities: The Case for Heat Stress Nephropathy....